Nkarta, Inc.
Developing NK cell therapies
- B2B
About Nkarta, Inc.
A biotech company developing allogeneic NK cell therapies using innovative cell engineering technologies to enhance tumor targeting and persistence
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- South San Francisco, California, United States
- Founded
- 2015
- Revenue
- $19.3M – $153MTamtam estimate
- Website
- nkartatx.com
- linkedin.com/company/nkarta-inc
Nkarta, Inc. at a glance
Nkarta, Inc. is a B2B company in the Biotechnology Research industry, headquartered in South San Francisco, California, United States.
Nkarta, Inc. was founded in 2015.
Nkarta, Inc. has 51–250 employees.
Nkarta, Inc.'s revenue is $19.3M – $153M (Tamtam estimate).
Frequently asked questions about Nkarta, Inc.
What is Nkarta, Inc.'s revenue?
Tamtam estimates Nkarta, Inc.'s annual revenue at $19.3M – $153M.
How many employees does Nkarta, Inc. have?
Nkarta, Inc. has 51–250 employees.
Where is Nkarta, Inc. headquartered?
Nkarta, Inc. is headquartered in South San Francisco, California, United States.
Selling to companies like Nkarta, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies